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As the pandemic of the coronavirus disease 2019 (COVID-19) continues while there is no drug and
vaccine available, every effort to discover one should be considered. This review aimed to discuss
the potential use of jamu, the Indonesian traditional herbal medicine, to deal with COVID-19 by
following those of more-established traditional Chinese medicine (TCM). The online literature
search using the PubMed database, as well as the circulars from the Indonesian Ministry of
Health, were carried out to collect data up to June 07, 2020. The use of TCM for the treatment
and prevention of COVID-19 has been officiated in the Chinese National Clinical Guideline on
COVID-19 Associated Pneumonia, with shen-fu-tang + su-he-xiang pill and xiang-sha-liu-junzitang as the most frequently suggested formulae to treat severe and recovery stages of COVID-19,
respectively. In Indonesia, the highly promoted product for the prevention of this disease is likely
the adaptation of a TCM formula, while the use of some other formulae, which mainly containing
Zingiberaceae, is suggested by the Government for the said purpose. The rationalization of the use
of medicinal plants and suggested polyherbal formulae, based on their available pharmacological
activity and the bioactive compounds, is also discussed in this review. The use of jamu for
COVID-19, however, needs to be carefully considered for the limited scientific data available to
support it.
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INTRODUCTION
Coronavirus disease 2019 (COVID-19) was announced
as a global pandemic in February 2020. The cases
exceeded 6.5 million cases and take toll death almost
400,000 people worldwide within four months, with the
number of the total cases in America and Europe five
times higher than those in Asia (WHO, 2020). Up to this
day, there is no drug or vaccine available for COVID-19
therapy despite a massive effort from scientists around
the world to discover them (Sanders et al., 2020).
Repurposed drugs such as hydroxychloroquine, which
initially seen as a prospective COVID-19 drug, have
been proven to have no clinical benefit in the latest report,
even though such a report has been claimed to be a flaw
and resulted in an article retraction. The latest report on
a double-blind, randomized, placebo-controlled trial
of Remdesivir, a protide nucleotide analogs, resulted
in shorter time recovery in hospitalized COVID-19
patients (Beigel et al., 2020). Hence, there is no clear
evidence yet for any drug or vaccine that is beneficial for
COVID-19 therapy.
The integrative treatment between conventional
medicines with the centuries longstanding traditional
ones, i.e., traditional Chinese medicine (TCM) and
Ayurvedha, is believed to be useful for COVID-19

treatment. These traditional medicine systems have been
part of Asian people’s life to treat any kind of illness.
TCM has been proven to provide beneficial prevention
for viral infection diseases, including influenza,
pandemic SARS, and H1N1 (Luo et al., 2020). Recently,
a case report mentioned the recovery of a highlysuspected COVID-19 patient who consumed qingfei-pai-du formula (Ren et al., 2020). In the Chinese
National Clinical Guideline on COVID-19 Associated
Pneumonia, several formulae of TCM are suggested to
treat each different disease stages (Chan et al., 2020).
Jamu, the Indonesian traditional herbal medicine, is
supposed to have similar potentials as those of TCM.
However, the report on jamu for COVID-19 treatment is
lacking up to this review is written.
In this review, the use of TCM, Ayurvedha, and jamu
for COVID-19 cases are discussed. We will focus on the
composition analysis on the most frequently suggested
formulae in the Chinese Guideline and elaborate on their
benefits claim. The information of the TCM formulae
is then used for analyzing a registered jamu formula
that is highly promoted and claimed for COVID-19
treatment in Indonesia, i.e., Herbavid-19. We also list
the medicinal plants and herbal medicine formulae
mentioned in the circulars from the Indonesian Ministry
of Health. Lastly, we explore the consideration that
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Table 1. Plant constituents of the most popular herbal formulae for the treatment of COVID-19 (Ang et al.,
2020)
Herbal
formulae
Shen-fu-tang
+ su-he-xiang
pill

Indicated
for
Severe
stage

Xiang-sha-liujunzi-tang

Recovery
stage

The basic
herbal composition
Panax ginseng C.A.Mey. roots, Aconitum carmichaelii Debeaux roots, Acorus
calamus L. rhizomes, Curcuma longa L. rhizomes, Cornus officinalis Siebold &
Zucc. pulps, Schisandra chinensis (Turcz.) Baill. fruits, Zingiber officinale Roscoe
rhizomes, and Glycyrrhiza glabra L. rhizomes and roots + Liquidambar orientalis
Mill. oleoresins
Codonopsis pilosula (Franch.) Nannf. roots, preserved Astragalus propinquus
Schischkin roots in honey, Atractylodes macrocephala Koidz. rhizomes, Wolfiporia
extensa (Peck) Ginns sclerotia, Glycyrrhiza glabra rhizomes, and roots

needs to be applied for jamu usage for COVID-19, as
well as the rationalization of the use of the suggested
medicinal plants and polyherbal formulae. The data
presented in this review were mainly retrieved from the
online database PubMed (https://pubmed.ncbi.nlm.nih.
gov/). The name of plants mentioned in this article is
written according to the accepted name in The Plant List
(http://www.theplantlist.org/).
TCM AND COVID-19
TCM is included in the sixth edition of the Chinese
COVID-19 Guideline since the 2nd edition to the final
7th one (Chan et al., 2020). Further, 23 provinces in
China have adapted this Guideline and issued TCM
program in the provincial Guideline on COVID-19
prevention, while 26 provinces officially established
the integrative TCM, which combined TCM with the
conventional treatment for the COVID-19 patient (Luo
et al., 2020; Yang Yang et al., 2020). More than 85%
of the total confirmed COVID-19 patients were reported
to have been treated with TCM. The treatment with
integrative Chinese–Western medicine was given to all
COVID-19 cases in Shanghai, while the first recovered
patient in Beijing was also treated with this combination
medication (Chan et al., 2020).
In the Chinese Guidelines, TCM is used for the
treatment of mild, moderate, severe, and recovery stages
of COVID-19, which utilized 23, 11, 31, and 21 herbal
formulae, respectively. Among those 75 formulae, there
are 17 most frequently recommended herbal formulae
in different guidelines. The most popular herbal
formulae are including shen-fu-tang + su-he-xiang
pill and xiang-sha-liu-junzi-tang (Ang et al., 2020).
A slight difference in the herbal compositions of those
formulae in each Guideline is evidenced, with the basic
herbal compositions is listed in Table 1. The exhaustive
evaluation of the available data on the Chinese medicines
for COVID-19, both traditional and modern, showed that
the benefits of treatment are mediated by its capability
for strengthening the body resistance and diminishing
viral pathogenic factors (Zhou et al., 2020).
E-ISSN 2477-0612

Glycyrrhiza glabra, Prunus armeniaca L., Ephedra
sinica Stapf., Scutellaria baicalensis Georgi, and
Atractylodes macrocephala were found to be the most
frequently used plants used to treat COVID-19, which
can be found in more than 35 herbal formulae (Ang et
al., 2020). Glycyrrhiza glabra rich with glycyrrhizin,
which showed antiviral activity against clinical SARS
coronavirus isolates. Also, the well-recognized antiinflammatory and immunomodulatory activities of this
plant might play significant roles in the treatment of
COVID-19 (F. Chen et al., 2004; R. Yang et al., 2015).
The potential efficacy of herbal medicines containing the
later four plants in the treatment of COVID-19 might be
related to their anti-inflammatory activities, which have
been proven in various models (L. G. Chen et al., 2016;
Liang et al., 2018; Minaiyan et al., 2014). Furthermore,
amygdalin of Prunus armeniaca and extract of
Scutellaria baicalensis protected bronchial epithelial
cells in mice model with chronic obstructive pulmonary
disease, while standardized extract of Scutellaria
baicalensis ameliorated influenza A virus-induced acute
lung injury (Jiao et al., 2019; W. K. Yang et al., 2019;
Zhi et al., 2019).
Another prominent traditional medicine system included
in the national Guideline of COVID-19 is Ayurveda,
which is believed to improve the immunity system
mediated by psychoneuroimmune mechanisms and the
meaning response (Golechha, 2020; Rajkumar, 2020).
One of the formulae championed for this purpose
is chyawanprash, which is traditionally used for its
immunomodulatory, antioxidant, and hepatoprotective
activities as well as respiratory system rejuvenation
effect (Sharma et al., 2019). The medicinal plants that
are recommended in the guidelines are includes Allium
sativum L., Cinnamomum verum J.Presl, Cuminum
cyminum L., Curcuma longa L., Ocimum tenuiflorum L.,
Withania somnifera (L.) Dunal, and Zingiber officinale
Roscoe. All of these recommended medicinal plants
exhibited the immunomodulatory properties in the
form of single plant preparation (Sheoran et al., 2017;
Subhrajyoti & Shalini, 2020; Tabarsa et al., 2020).
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Table 2. Rationalization of the use of the suggested medicinal plants for dealing with COVID-19 symptoms and maintaining the immune system
Plant name

Plant part

The main bioactive compounds The underlying pharmacological activity

Curcuma longa

Rhizomes

Curcumin and a polysaccharide
as immunomodulators (Salehi
et al., 2019; G. G. L. Yue et al.,
2010)

Curcumin nanoparticles significantly stimulated primary humoral immune response and secondary
humoral antibody titers in mice (Afolayan et al., 2018). Curcumin modulated the immune responses
and might play a dominant role in the treatment of inflammation and metabolic diseases (Srivastava
et al., 2011).
Prolonged curcumin-injections was safe for functions of natural killer cells and antioxidative functions
of macrophages as well as enhanced the mitogen and antigen-induced proliferation potential of T-cell
(Varalakshmi et al., 2008).

Curcuma
zanthorrhiza
Zingiber officinale
var Rubrum

Rhizomes

Psidium guajava

Leaves

Phyllantus niruri

Rhizomes

Aerial parts

A polysaccharide stimulated in-vitro peripheral blood mononuclear cells (PBMCs) proliferation and
cytokine production (G. G. L. Yue et al., 2010).
Curcumin as immunomodulator The methanolic extract showed significant inhibitory activity on CD18/11a expression (Harun et al.,
2015).
6-gingerol, 6-shogaol, and The oleoresin microcapsules showed antioxidant activity (Jayanudin et al., 2019).
8-shogaol
as
antioxidants
The ethanolic extract had antioxidant activity (Ghasemzadeh et al., 2016).
(Ghasemzadeh et al., 2016)
Quercetin and other polyphenols
as immunostimulant; quercetin,
gallic acid, ferulic acid, and
caffeic acid as antioxidant
(Gutiérrez et al., 2008; Laily et
al., 2015)
Phyllanthin, hypophyllanthin,
niranthin,
phyltetralin,
astragalin, quercetin, corilagin,
catechin,
geraniin,
gallic
acid, and ellagic acid as
immunomodulator (Jantan et al.,
2019)

The water and ethanolic extracts exerted in-vitro immunostimulatory activity in the lymphocyte
proliferation assay (Laily et al., 2015).
The crude ethanolic extract, its fractions, and some isolated compounds exhibited immunomodulatory
effects in the head kidney leukocytes of striped catfish (Nhu et al., 2020).
The aqueous extract was capable of dose-dependently inducing proliferation of PBMCs, increasing the
release of nitric oxide, and enhancing phagocytic activity of macrophages isolated from tuberculosis
patients (Putri et al., 2018).
The aqueous extract exerted anti-inflammatory and antinociceptive activities in rats carrageenan- and
histamine-induced rats and acetic acid-induced mice, respectively (Adedapo & Ofuegbe, 2015).
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Table 2. continued
Plant name

Plant part

The main bioactive compounds The underlying pharmacological activity

Andrographis
paniculata

Aerial parts

Andrographolide and other
related
diterpene
lactones
as
immunomodulator;
5 - h y d r o x y - 7 , 8 dimethoxyflavone, 5-hydroxy7,8-dimethoxyflavanone,
β-sitosterol,
stigmasterol,
ergosterol
peroxide,
1 4 - d e o x y - 1 4 , 1 5 dehydroandrographolide, and
19-O-acetyl-14-deoxy-11,12didehydroandrographolide
as
antiinflammatory (Chao et al.,
2010; Hossain et al., 2014).

The aqueous extract stimulated the proliferation of PBMCs and increasing the production of TNF-α
and IFN-γ, as well as modulated the number of regulatory T cells in the carcinogen-induced esophageal
cancerous rats (G. G.-L. Yue et al., 2019).

Niaziminin
B
as
immunomodulator; kaempferol3-glucoside and chlorogenic
acid as analgesic (Agarwal &
Ambwani, 2018; MartínezGonzález et al., 2017)

The methanolic extract increased the count of white blood cells, lymphocyte, and neutrophil in
cyclophosphamide-immunocompromised rats (Nfambi et al., 2015).

Moringa oleifera

Allium sativum

E-ISSN 2477-0612

Leaves

Bulbs

The isolated anti-inflammatory compounds showed transcriptional inhibitory activity of NF-kappaB,
as well as secretory reduction of TNF-alpha, IL-6, macrophage inflammatory protein-2 (MIP-2), and
nitric oxide (NO) in LPS/IFN-gamma, stimulated RAW 264.7 macrophages (Chao et al., 2010).

The hexane and ethanolic extracts showed antinociceptive, antiinflammatory, and antiarthritis induced
by formalin, carrageenan, and collagen in rats, respectively (Martínez-González et al., 2017).

Diallyl monosulfide, diallyl The mixture of diallyl polysulfides decreased interleukin-12 (IL12) levels in PBMCs (Oosthuizen et
disulfide, diallyl trisulfide, diallyl al., 2017).
tetrasulfide, diallyl pentasulfide,
and diallyl hexasulfide as
immunomodulators (Oosthuizen
et al., 2017)
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JAMU AND COVID-19
In contrast, the use of jamu is not recognized in the
Guideline of COVID-19 Patients (Indonesian Society of
Respirology, 2020). Despite a lack of scientific proof,
several medicinal plants and herbal medicines have
been championed and highly consumed by Indonesian
in the hope that they will be protected from contracting
the virus. Among those herbal medicines, Herbavid-19®
was the highly promoted jamu for the COVID-19
medication. It consists of Arctium lappa L. fruits, Coix
lacryma-jobi L. kernels, Curcuma zanthorrhiza Roxb.
rhizomes, Forsythia suspensa (Thunb.) Vahl. fruits,
Glycyrrhiza glabra L. roots, Imperata cylindrica (L.)
Raeusch. rhizomes, Lonicera japonica Thunb. flowers,
Lophatherum gracile Brongn. leaves, Mentha arvensis
L. leaves, Pogostemon cablin (Blanco) Benth. leaves,
and Nepeta tenuifolia Benth. Leaves. Herbavid-19® was
registered with the claims of helping to maintain the
immune system and relieve the symptoms associated
with cough, fever, and sore throat (Indonesian NADFC,
2020b). Although Herbavid-19® is registered as
traditional medicine made in Indonesia, its formula
resemble the classical TCM yin-qiao formula, which
mainly consists of the primary plant materials of
Lonicera japonica and Forsythia suspensa. Yin-qiao
is traditionally used for the prevention and treatment
of respiratory tract infection and has been proven to
improve the function of the upper respiratory mucosal
immune system of mice with bacteria- and virusesstimulated upper respiratory mucosal dysfunction (Liu
et al., 2015). Yin-qiao-san is another modification of
yin-qiao included in the Chinese COVID-19 Guideline,
which is mostly used in combination for the treatment
of mild and moderate stages of COVID-19. For mild
cases, yin-qiao-san is particularly indicated for expelling
phlegm, relieving cough, and restoring normal lung
function in feverish patients (Ang et al., 2020; Xu &
Zhang, 2020). Previously, yin-qiao-san, in combination
with ma-xing-shi-gan, has clinically proven to reduce the
time of fever resolution in patients with mild infection of
H1N1 virus (Wang et al., 2011). However, yin-qiao-san
is not included in the Chinese Guideline or evaluated in
any on-going clinical trials of TCM for the treatment of
COVID-19 (Yang Yang et al., 2020).
The Indonesian Government has suggested the use of
some medicinal plants as immunostimulatory agents to
deal with COVID-19 based on the available safety and
efficacy data. These medicinal plants are Curcuma longa,
Curcuma zanthorrhiza, Zingiber officinale Roscoe var
Rubrum, Psidium guajava L, Phyllantus niruri L, and
Andrographis paniculata (Burm.f.) Nees (Indonesian
NADFC, 2020d). The use of Moringa oleifera Lam. and
Allium sativum for their immunomodulatory activity
and capability of relieving the symptoms of COVID-19
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i.e., cough and sore throat, are also proposed by the
Government. There are some herbal formulae intended
for the same purpose as well (see Table 3), in which palm
sugar (processed from exudates of Cocos nucifera L. or
Arenga pinnata (Wurmb) Merr.) is commonly added to
enhance the taste of the concoction (Ministry of Health
of the Republic of Indonesia, 2020).
Recently, the Government published ‘Informatorium
Obat Modern Asli Indonesia (OMAI) di Masa Pandemi
COVID-2019’. The OMAI term refers to standardized
herbal medicine and fitofarmaka products, which
according to the regulation of the Head of National
Agency of Drug and Food Control no HK.00.05.4.2411,
are those with standardized active constituents and
have shown efficacy in preclinical or clinical studies.
In total, there are 15 standardized herbal medicine and
ten phytomedicine products available for dealing with
COVID-19 symptoms or improving the immune system
included in the informatory (Indonesian NADFC,
2020c). Furthermore, there are two immunomodulatory
products registered as traditional medicines that are
being clinically evaluated in patients with COVID-19 in
June 2020. The first product is prepared from Cordyceps
militaris (L.) Fr. sclerotia, while the second one is the
polyherbal formula consist of Zingiber officinale var
Rubrum rhizomes, Phyllanthus niruri aerial parts,
Andrographis paniculata aerial parts, and Blumea
balsamifera (L.) DC. leaves (Indonesian NADFC,
2020a; Uly, 2020).
CONSIDERATION OF JAMU USES FOR COVID-19
The COVID-19 pandemic brings opportunities and
challenges for researchers to discover effective
treatments, including those originated from herbal
medicines. Exploration of the active compounds from the
natural product is a strategy that should not be missed,
but the rush on claiming the efficacy without sufficient
scientific evidence must be avoided. In Indonesia, herbal
medicines are grouped into three categories, i.e., jamu,
standardized herbal medicine, and fitofarmaka. The
efficacy claim of jamu is based on the empirical data
although the biological activity of commonly used plants
in jamu has been scientifically investigated (Elfahmi et
al., 2014). Indonesian Government encourages the use of
the potential domestic resources for handling COVID-19.
However, there is no herbal medicine that is registered for
the prevention and treatment of COVID-19 in Indonesia.
The claim of the efficacy of the products available for
dealing with COVID-19 is more on the function of
maintaining and increasing the human immune system.
The widely used of herbal products, especially the
products which claim formaintaining the human immune
system and is associated with COVID-19 prevention or
treatment, needs to be carefully considered and well
E-ISSN 2477-0612
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Table 3. Rationalization of the use of the suggested herbal formulae for dealing with COVID-19 symptoms and maintaining the immune system
Formula name: Plant constituents The main bioactive compounds The underlying pharmacological activity

Traditional uses

Formula 1: Cinnamomum verum
barks, Citrus aurantifolia (Christm.)
Swingle fruits, and Zingiber
officinale var. Rubrum rhizomes

The variation of the wedhang jahe, traditionally
used for warming the body, improving the appetite,
aiding digestion, and helping with rheumatic pain
(Beers, 2001)

Trans-cinnamaldehyde
and
its analogs of Cinnamomum
verum as immunomodulators;
6-gingerol,
6-shogaol,
and
8-shogaol of Zingiber officinale
var. Rubrum as antioxidants
(Qadir et al., 2018)

The inhibition of CD18/11a expression of
leukocytes and enhancement phagocytosis of
leukocytes by Citrus aurantifolia, amelioration
of collagen type-II induced arthritis in mice by
Cinnamomum verum, and antioxidant activity of
Zingiber officinale var Rubrum
(Harun et al., 2015; Qadir et al., 2018)

Formula 2: Alpinia galanga (L.) Curcumin and a polysaccharide The modulation of the phagocytes innate The modification of the classical jamu kunyit asam
immune response by Alpinia galangal, formula, traditionally used as a general tonic for
Willd rhizomes., Citrus aurantifolia as immunomodulators
immunomodulatory
activity
of
Citrus maintaining overall health (Andrie et al., 2014)
fruits,and Curcuma longa rhizomes
aurantifolia and Curcuma longa (Jantan et al.,
2011)
Formula 3: Curcuma zanthorrhiza
rhizomes, Phyllanthus niruri aerial
parts, and Zingiber officinale var.
Rubrum rhizomes

Phyllanthin and the related
phenolic
compounds
of
Phyllanthus
niruri
as
immunomodulators; 6-gingerol,
6-shogaol, and 8-shogaol of
Zingiber officinale var. Rubrum
as antioxidants

The immunomodulatory, anti-inflammatory, and The variation of the classical jamu temulawak,
antinociceptive activities of Phyllanthus niruri traditionally used for hepatoprotection (Tampubolon
and Curcuma zanthorrhiza; the antioxidant et al., 2014)
activity of Zingiber officinale var. Rubrum
(Adedapo & Ofuegbe, 2015; Putri et al., 2018)

Formula 4: Kaempferia galanga L.
rhizomes, Oryza sativa L starches,
and Pandanus amaryllifolius Roxb.,
leaves

Polysaccharides of Oryza sativa
as immunomodulator, essential
oil of Pandanus amaryllifolius as
relaxant (Pradopo et al., 2017; L.
C. Yang et al., 2015)

The inhibition of CD18/11a expression of
leukocytes and enhancement phagocytosis
of leukocytes by Kaempferia galanga,
enhancement of macrophage phagocytosis
and cytokine inductions by Oryza sativa, and
reduction in blood pressure and pulse rate effects
of Pandanus amaryllifolius (Harun et al., 2015;
Pradopo et al., 2017; L. C. Yang et al., 2015)

E-ISSN 2477-0612

The variation of the classical jamu beras kencur
formula, traditionally used for a general tonic and
invigorating, relieving tiredness, improving blood
circulation and appetite (Beers, 2001)
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communicated to the public. Nevertheless, scientific
studies to prove the efficacy of popular products need to
be conducted.
There are four aspects need to be considered in the use
of jamu to deal with COVID-19. First, the safety of the
product should be guaranteed. Although jamu is used for
a long time, there is no such evidence that the use of
COVID-19 treatment is safe. The use of herbal medicines
for therapeutic purposes on COVID-19 focused on the
symptoms relieving as it is generally showed the best
benefits in the chronic, ongoing post-infection symptoms
rather than its acute stage (Wardle, 2020). While most
of the herbal medicines exhibit immunomodulatory
properties, cytokine storms which is caused by the hyperstimulation of the immune system, is characterized as
the most dangerous and potentially life-threatening
event related to COVID-19 (Coperchini et al., 2020;
Wardle, 2020). Second, the evidence of the safety and
efficacy of herbal medicines should be obtained based on
the clinical trials. As of March 2020, there are 14 clinical
trials of TCM for the treatment of COVID-19 (Yang
Yang et al., 2020). In June 2020, there are two clinical
trials of Indonesian herbal products for the same purpose
in Jakarta. However, until to date, there is no result of
those studies being published. Before the clinical trial of
the herbal products is conducted, pre-clinical data must
show the promising results on its safety and efficacy for
further development steps. The efficacy data obtained
from both in-vitro and in-vivo studies can be used as the
rationale for the further clinical trial of selected plants or
polyherbal formulae for prevention and alleviating the
symptoms of COVID-19. The main bioactive compounds
and the underlying pharmacological activities of the
suggested medicinal plants and polyherbal formulae
associated with COVID-19 are listed in Table 2 and 3,
respectively.
Third, the molecular mechanism underlined the
pharmacological effects of herbal medicine in
COVID-19 treatment is still unclear. So far, the available
data are obtained from the in-silico experiments, e.g.,
screening of classical TCM used for treating viral
respiratory infection demonstrated that the active
compounds exerted its activities through regulation of
viral infection, immune and inflammation reactions, as
well as hypoxia responses. In addition, hesperidin, a
flavonoid commonly found in Citrus sp. peels, which
is popularly championed to be natural prevention of
COVID-19 in Indonesia, was reported to bind strongly
to human angiotensin-converting enzyme-2 (hACE-2)
and RNA dependent RNA polymerase (RdRp) as SARSCoV-2 infection potential targets (Joshi et al., 2020;
Zhang et al., 2020). Lastly, the potential danger of the
delay in medical treatment due to jamu consumption
should be recognized. Since herbal medicines are sold
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as over the counter product and can be accessed without
a doctor’s prescription, their use as self-treatment of
COVID-19 by patients who experience symptoms is
highly possible (Yichang Yang, 2020). Jamu, and other
herbal medicines, in general, should not be used in an
emergency condition, including in the acute phase
of viral infection. Delay in getting the right treatment
in COVID-19 cases prolong the recovery process. In
fact, in some cases, this delay can be fatal if the virus
continues to replicate quickly in the patient’s body.
It is crucial to communicate the safe practice of jamu
uses to the public. The products registered by the
National Agency of Drug and Food Control are, at
least, guaranteed to be safe to use, and hence should be
the first criteria to be considered before consumption.
Furthermore, the packaging, label, and expired date of
a given product should be checked before it is used.
In case jamu is self-prepared from raw material in the
household setting, the selection and identification of
the raw materials, the washing process, boiling process,
the equipment used and also the overall sanitation and
hygiene aspects need to be considered as they affect
both its efficacy and safety (Ministry of Health of the
Republic of Indonesia, 2020).
CONCLUSION
Unlike the prominent position of TCM for the treatment
and prevention of COVID-19 in China, the use of jamu
in Indonesia still has to take a long and steepy way to be
used for this purpose. Further studies on the efficacy and
safety of jamu products for COVID-19 in humans and
also its molecular mechanisms are needed. Additionally,
the safe use of both registered and suggested homemade jamu products should be well communicated to
the public.
REFERENCES
Adedapo, A. A., & Ofuegbe, S. O. (2015). Antiinflammatory and antinociceptive activities of the
aqueous leaf extract of Phyllanthus amarus Schum
(Euphorbiaceae) in some laboratory animals. Journal
of Basic and Clinical Physiology and Pharmacology,
26(1), 89–94. https://doi.org/10.1515/jbcpp-2013-0126.
Afolayan, F. I. D., Erinwusia, B., & Oyeyemi, O. T.
(2018). Immunomodulatory activity of curcuminentrapped poly d,l-lactic-co-glycolic acid nanoparticles
in mice. Integrative Medicine Research, 7(2), 168–175.
https://doi.org/10.1016/j.imr.2018.02.004
Agarwal, M., & Ambwani, S. (2018). Exploring the
immunomodulatory potential of niaziminin B found
in Moringa oliefera Lam. in chicken through in silico
E-ISSN 2477-0612

The Potential Roles of Jamu for COVID-19

modeling and molecular docking studies. Bulletin of
Environment, Pharmacology and Life Sciences, 7(11),
32–36.
Andrie, M., Taurina, W., & Ayunda, R. (2014). Uji
aktivitas jamu gendong Kunyit asam (Curcuma
domestica Val.; Tamarindus indica L.) sebagai
antidiabetes pada tikus yang diinduksi Streptozotocin.
Traditional Medicine Journal, 19(2), 95–102. https://
doi.org/10.22146/tradmedj.8147.
Ang, L., Lee, H. W., Choi, J. Y., Zhang, J., & Lee, M.
S. (2020). Herbal medicine and pattern identification
for treating COVID-19: A rapid review of guidelines.
Integrative Medicine Research, 9(2), article ID 100407.
https://doi.org/10.1016/j.imr.2020.100407.
Beers, S.-J. (2001). Jamu: The ancient Indonesian art of
herbal healing. Tuttle Publishing.
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta,
A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu,
H. Y., Luetkemeyer, A., Kline, S., De-Castilla, D. L.,
Finberg, R. W., Dierberg, K., Tapson, V., Hsieh, L.,
Patterson, T. F., Paredes, R., Sweeney, D. A., Short, W.
R., … Lane, H. C. (2020). Remdesivir for the treatment
of Covid-19 - preliminary report. The New England
Journal of Medicine, 1–12. https://doi.org/10.1056/
NEJMoa2007764.
Chan, K. W., Wong, V. T., & Tang, S. C. W. (2020).
COVID-19: An update on the epidemiological, clinical,
preventive and therapeutic evidence and guidelines
of integrative Chinese–Western medicine for the
management of 2019 novel coronavirus disease. The
American Journal of Chinese Medicine, 48(3), 1–26.
https://doi.org/10.1142/S0192415X20500378.
Chao, W.-W., Kuo, Y.-H., & Lin, B.-F. (2010). Antiinflammatory activity of new compounds from
Andrographis paniculata by NF-KB transactivation
inhibition. Journal of Agricultural and Food Chemistry,
58(4), 2505–2512. https://doi.org/10.1021/jf903629j.
Chen, F., Chan, K. H., Jiang, Y., Kao, R. Y. T., Lu, H. T.,
Fan, K. W., Cheng, V. C. C., Tsui, W. H. W., Hung, I. F.
N., Lee, T. S. W., Guan, Y., Peiris, J. S. M., & Yuen, K.
Y. (2004). In vitro susceptibility of 10 clinical isolates
of SARS coronavirus to selected antiviral compounds.
Journal of Clinical Virology, 31(1), 69–75. https://doi.
org/10.1016/j.jcv.2004.03.003.
Chen, L. G., Jan, Y. S., Tsai, P. W., Norimoto, H.,
Michihara, S., Murayama, C., & Wang, C. C. (2016).
Anti-inflammatory and antinociceptive constituents of
Atractylodes japonica Koidzumi. Journal of Agricultural
E-ISSN 2477-0612

Pharm Sci Res, Vol 7 Special Issue on COVID-19, 2020

19

and Food Chemistry, 64(11), 2254–2262. https://doi.
org/10.1021/acs.jafc.5b05841.
Coperchini, F., Chiovato, L., Croce, L., Magri, F., &
Roton, M. (2020). The cytokine storm in COVID-19:
An overview of the involvement of the chemokine/
chemokine-receptor system. Cytokine & Growth
Factor Reviews, In press, corrected proof. https://doi.
org/10.1016/j.cytogfr.2020.05.003.
Elfahmi, Herman J. Woerdenbag, & Kayser, O. (2014).
Jamu: Indonesian traditional herbal medicine towards
rational phytopharmacological use. Journal of Herbal
Medicine, 4(2), 51–73. https://doi.org/http://dx.doi.
org/10.1016/j.hermed.2014.01.002.
Ghasemzadeh, A., Jaafar, H. Z. E., & Rahmat, A.
(2016). Variation of the phytochemical constituents and
antioxidant activities of Zingiber officinale Var. Rubrum
Theilade associated with different drying methods and
polyphenol oxidase activity. Molecules, 21(6), article
780. https://doi.org/10.3390/molecules21060780.
Golechha, M. (2020). Time to realise the true potential
of Ayurveda against COVID-19. Brain, Behavior,
and Immunity, In press, corrected proof. https://doi.
org/10.1016/j.bbi.2020.05.003.
Gutiérrez, R. M. P., Mitchell, S., & Solis, R. V.
(2008). Psidium guajava: A review of its traditional
uses, phytochemistry and pharmacology. Journal
of Ethnopharmacology, 117(1), 1–27. https://doi.
org/10.1016/j.jep.2008.01.025.
Harun, N. H., Septama, A. W., & Jantan, I. (2015).
Immunomodulatory effects of selected Malaysian plants
on the CD18/11a expression and phagocytosis activities
of leukocytes. Asian Pacific Journal of Tropical
Biomedicine, 5(1), 48–53. https://doi.org/10.1016/
S2221-1691(15)30170-2.
Hossain, M. S., Urbi, Z., Sule, A., & Rahman, K. M.
H. (2014). Andrographis paniculata (Burm. f.) Wall.
ex Nees: A review of ethnobotany, phytochemistry,
and pharmacology. The Scientific World Journal, 2014,
27490. https://doi.org/10.1155/2014/274905.
Indonesian NADFC. (2020a). Cek Produk BPOM:
H2 Health & Happiness Cordyceps militaris. http://
cekbpom.pom.go.id/index.php/home/produk/
l89nuprd8mo53gl6ldgmvdv922/all/row/10/page/1/
order/4/DESC/search/0/TR162397831.
Indonesian NADFC. (2020b). Cek Produk BPOM:
Herbavid-19.
http://cekbpom.pom.go.id/index.php/
home/produk/sk63uosoguna8ro0vckk4quc31/all/

20

Pharm Sci Res, Vol 7 Special Issue on COVID-19, 2020

row/10/page/1/order/4/DESC/search/1/Herbavid.
Indonesian NADFC. (2020c). Informatorium obat
modern asli Indonesia (OMAI) di masa pandemi
COVID-2019 (1st ed.). Badan Pengawas Obat dan
Makanan.
Indonesian NADFC. (2020d). Pedoman Penggunaan
Herbal dan Suplemen Kesehatan dalam Menghadapi
COVID-19 di Indonesia (1st ed.). National Agency of
Drug and Food Control of Republic of Indonesia. https://
online.flipbuilder.com/aeqr/texx/mobile/index.html.
Indonesian Society of Respirology. (2020). Protokol
Tatalaksana COVID-19 (1st ed.). PDPI - PERKI PAPDI - PERDATIN - IDAI.
Jantan, I., Haque, M. A., Ilangkovan, M., & Arshad,
L. (2019). An insight into the modulatory effects and
mechanisms of action of Phyllanthus species and their
bioactive metabolites on the immune system. Frontiers in
Pharmacology, 10, article 878. https://doi.org/10.3389/
fphar.2019.00878.
Jantan, I., Harun, N. H., Septama, A. W., Murad, S., &
Mesaik, M. A. (2011). Inhibition of chemiluminescence
and chemotactic activity of phagocytes in vitro by the
extracts of selected medicinal plants. Journal of Natural
Medicines, 65(2), 400–405. https://doi.org/10.1007/
s11418-010-0492-8.
Jayanudin, Fahrurrozi, M., Wirawan, S. K., &
Rochmadi. (2019). Antioxidant activity and controlled
release analysis of red ginger oleoresin (Zingiber
officinale var rubrum) encapsulated in chitosan crosslinked by glutaraldehyde saturated toluene. Sustainable
Chemistry and Pharmacy, 12, article 100132. https://
doi.org/10.1016/j.scp.2019.100132.
Jiao, J., Yang, Y., Wu, Z., Li, B., Zheng, Q., Wei, S., Wang,
Y., & Yang, M. (2019). Screening cyclooxygenase-2
inhibitors from Andrographis paniculata to treat
inflammation based on bio-affinity ultrafiltration coupled
with UPLC-Q-TOF-MS. Phytotherapia, 137, article
104259. https://doi.org/10.1016/j.fitote.2019.104259.
Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S.
S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P.,
& Kulkarni, M. J. (2020). Discovery of potential multitarget-directed ligands by targeting host-specific SARSCoV-2 structurally conserved main protease. Journal of
Biomolecular Structure and Dynamics, 5, 1–16. https://
doi.org/10.1080/07391102.2020.1760137
Laily, N., Kusumaningtyas, R. W., Sukarti, I., & Rini,
M. R. D. K. (2015). The potency of guava Psidium

Hartanti, et al.

guajava (L.) leaves as a functional immunostimulatory
ingredient. Procedia Chemistry, 14, 301–307. https://
doi.org/10.1016/j.proche.2015.03.042.
Liang, S., Meng, X., Wang, Z., Liu, J., Kuang, H., &
Wang, Q. (2018). Polysaccharide from Ephedra sinica
Stapf inhibits inflammation expression by regulating
factor-β1/Smad2 signaling. International Journal of
Biological Macromolecules, 106, 947–954. https://doi.
org/10.1016/j.ijbiomac.2017.08.096.
Liu, L.-S., Lei, N., Lin, Q., Wang, W.-L., Yan, H.-W.,
& Duan, X.-H. (2015). The effects and mechanism of
yinqiao powder on upper respiratory tract infection.
International Journal of Biotechnology for Wellness
Industries, 4, 57–60.
Luo, H., Tang, Q. L., Shang, Y. X., Liang, S. B., Yang, M.,
Robinson, N., & Liu, J. P. (2020). Can Chinese medicine
be used for prevention of corona virus disease 2019
(COVID-19)? A review of historical classics, research
evidence and current prevention programs. Chinese
Journal of Integrative Medicine, 17, 1–8. https://doi.
org/10.1007/s11655-020-3192-6.
Martínez-González, C. L., Martínez, L., MartínezOrtiz, E. J., González-Trujano, M. E., Déciga-Campos,
M., Ventura-Martínez, R., & Díaz-Reval, I. (2017).
Moringa oleifera, a species with potential analgesic
and
anti-inflammatory
activities.
Biomedicine
and Pharmacotherapy, 87, 482–488. https://doi.
org/10.1016/j.biopha.2016.12.107.
Minaiyan, M., Ghannadi, A., Asadi, M., Etemad, M.,
& Mahzouni, P. (2014). Anti-inflammatory effect of
Prunus armeniaca L. (apricot) extracts ameliorates
TNBS-induced ulcerative colitis in rats. Research in
Pharmaceutical Sciences, 9(4), 225–231.
Ministry of Health Republic of Indonesia. Surat
Edaran tentang Pemanfaatan Obat Tradisional untuk
Pemeliharaan Kesehatan, Pencegahan Penyakit, dan
Perawatan Kesehatan, HK.02.02/IV.2243/2020 (2020)
(testimony of Indonesian MoH).
Nfambi, J., Bbosa, G. S., Sembajwe, L. F., Gakunga,
J., & Kasolo, J. N. (2015). Immunomodulatory activity
of methanolic leaf extract of Moringa oleifera in wistar
albino rats. Journal of Basic and Clinical Physiology and
Pharmacology, 26(6), 603–611. https://doi.org/10.1515/
jbcpp-2014-0104
Nhu, T. Q., Dam, N. P., Hang, B. T. B., Bach, L. T.,
Huong, D. T. T., Hue, B. T. B., Scippo, M.-L., Phuong,
N. T., Quetin-Leclercq, J., & Kestemont, P. (2020).
Immunomodulatory potential of extracts, fractions
E-ISSN 2477-0612

The Potential Roles of Jamu for COVID-19

and pure compounds from Phyllanthus amarus and
Psidium guajava on striped catfish (Pangasianodon
hypophthalmus) head kidney leukocytes. Fish and
Shellfish Immunology, 104, 289–303. https://doi.
org/10.1016/j.fsi.2020.05.051.

Pharm Sci Res, Vol 7 Special Issue on COVID-19, 2020

21

Chyawanprash: A traditional Indian bioactive health
supplement. Biomolecules, 9(5), article 161. https://doi.
org/10.3390/biom9050161.

Oosthuizen, C., Arbach, M., Meyer, D., Hamilton, C.,
& Lall, N. (2017). Diallyl polysulfides from Allium
sativum as immunomodulators, hepatoprotectors, and
antimycobacterial agents. Journal of Medicinal Food,
20(17), 685–690. https://doi.org/10.1089/jmf.2016.0137

Sheoran, N., Kumar, R., Kumar, A., Batra, K., Sihag,
S., Maan, S., & Maan, N. S. (2017). Nutrigenomic
evaluation of garlic (Allium sativum) and holy basil
(Ocimum sanctum) leaf powder supplementation on
growth performance and immune characteristics in
broilers. Veterinary World, 10(1), 121–129. https://doi.
org/10.14202/vetworld.2017.121-129.

Pradopo, S., Sinaredi, B. R., & Januarisca, B. V. (2017).
Pandan leaves (Pandanus amaryllifolius) aromatherapy
and relaxation music to reduce dental anxiety of pediatric
patients. Journal of International Dental and Medical
Research, 10(3), 933–937.

Srivastava, R. M., Singh, S., Dubey, S. K., Misra,
K., & Khar, A. (2011). Immunomodulatory and
therapeutic activity of curcumin. International
Immunopharmacology, 1(3), 331–341. https://doi.
org/10.1016/j.intimp.2010.08.014.

Putri, D. U., Rintiswati, N., Soesatyo, M. H., & Haryana,
S. M. (2018). Immune modulation properties of herbal
plant leaves: Phyllanthus niruri aqueous extract on
immune cells of tuberculosis patient - in vitro study.
Natural Product Research, 32(4), 463–467. https://doi.
org/10.1080/14786419.2017.1311888.

Subhrajyoti, C., & Shalini. (2020). Immunomodulatory
herbs of Ayurveda and COVID-19: A review article.
Journal of Ayurveda and Integrated Medical Sciences,
5(2), 203–208.

Qadir, M. M. F., Bhatti, A., Ashraf, M. U., Sandhu, M.
A., Anjum, S., & John, P. (2018). Immunomodulatory
and therapeutic role of Cinnamomum verum
extracts in collagen-induced arthritic BALB/c mice.
Immunopharmacology, 26(1), 157–170. https://doi.
org/10.1007/s10787-017-0349-9.
Rajkumar, R. P. (2020). Ayurveda and COVID-19: Where
psychoneuroimmunology and the meaning response
meet. Brain, Behavior, and Immunity, In press, corrected
proof. https://doi.org/10.1016/j.bbi.2020.04.056.
Ren, J. L., Zhang, A. H., & Wang, X. J. (2020).
Traditional Chinese medicine for COVID-19 treatment.
Pharmacological Research, 155, article 104743. https://
doi.org/10.1016/j.phrs.2020.104743.
Salehi, B., Stojanović-Radić, Z., Matejić, J., SharifiRad, M., Kumar, N. V. A., Martins, N., & Sharifi-Rad,
J. (2019). The therapeutic potential of curcumin: A
review of clinical trials. European Journal of Medicinal
Chemistry, 163, 527–545. https://doi.org/10.1016/j.
ejmech.2018.12.016.
Sanders, J. M., Monogue, M. L., & Jodlowski, T. Z.
(2020). Pharmacologic treatments for coronavirus
disease 2019 (COVID-19): A review. JAMA, 323(18),
1824–1836. https://doi.org/10.1001/jama.2020.6019.
Sharma, R., Martins, N., Kuca, K., Chaudhary, A.,
Kabra, A., Rao, M. M., & Prajapati, P. K. (2019).
E-ISSN 2477-0612

Tabarsa, M., You, S. G., Yelithao, K., Palanisamy, S.,
Prabhu, N. M., & Nan, M. (2020). Isolation, structural
elucidation and immuno-stimulatory properties of
polysaccharides from Cuminum cyminum. Carbohydrate
Polymers, 230, article 115636. https://doi.org/10.1016/j.
carbpol.2019.115636.
Tampubolon, S. R., Ardana, I. B. K., & Sudira, I. W.
(2014). Aktivitas alanin aminotransferase dan aspartat
aminotransferase pada mencit yang diberikan jamu
temulawak. Indonesia Medicus Veterinus, 3(3), 200–
205.
Uly, Y. A. (2020, June 10). LIPI uji coba obat herbal ke
90 pasien COVID-19 di Wisma Atlet. Kompas. https://
www.kompas.com/sains/read/2020/06/10/182943523/
lipi-uji-coba-obat-herbal-ke-90-pasien-covid-19-diwisma-atlet?page=all.
Varalakshmi, C., Ali, A. M., Pardhasaradhi, B. V.
V, Srivastava, R. M., Singh, S., & Khar, A. (2008).
Immunomodulatory effects of curcumin: In-vivo.
International Immunopharmacology, 8(5), 688–700.
https://doi.org/10.1016/j.intimp.2008.01.008.
Wang, C., Pan, R., Wan, X., Tan, Y., Xu, L., Ho, C. S.,
& Ho, R. C. (2020). Immediate psychological responses
and associated factors during the initial stage of the
2019 coronavirus disease (COVID-19) epidemic among
the general population in China. International Journal
of Environmental Research and Public Health, 17(5),
article 1729. https://doi.org/10.3390/ijerph17051729.

22

Pharm Sci Res, Vol 7 Special Issue on COVID-19, 2020

Wardle, J. (2020). Traditional and complementary
treatments do have a role to play in global health, but
probably not in emerging pandemics. Advances in
Integrative Medicine, 7, 1–2. https://doi.org/10.1016/j.
aimed.2020.02.003.
WHO. (2020). Coronavirus disease (COVID-2019)
situation reports. https://www.who.int/emergencies/
diseases/novel-coronavirus-2019/situation-reports.
Xu, J., & Zhang, Y. (2020). Traditional Chinese medicine
treatment of COVID-19. Complimentary Therapies
in Clinical Practice, 39, article ID 101165. 10.1016/j.
ctcp.2020.101165.
Yang, L. C., Hsieh, C. C., & Lin, W. C. (2015).
Characterization and immunomodulatory activity of
rice hull polysaccharides. Carbohydrate Polymers, 124,
150–156. https://doi.org/10.1016/j.carbpol.2015.02.025.
Yang, R., Wang, L. I., Yuan, B. C., & Liu, Y.
(2015). The pharmacological activities of licorice.
Planta Medica, 81(18), 1654–1669. https://doi.
org/10.1055/s-0035-1557893.
Yang, W. K., Kim, S. H., Jung, I. C., & Park, Y. C. (2019).
Effects of Scutellaria baicalensis extract on cigarette
smoke-induced airway inflammation in a murine model
of chronic obstructive pulmonary disease. Journal of
Medicinal Food, 22(1), 87–96. https://doi.org/10.1089/
jmf.2018.4200.
Yang, Yang, Islam, M. S., Wang, J., Li, Y., & Chen, X.
(2020). Traditional Chinese medicine in the treatment
of patients infected with 2019-new coronavirus (SARSCoV-2): A review and perspective. International Journal
of Biological Sciences, 16(10), 1708–1717. https://doi.
org/10.7150/ijbs.45538.
Yang, Yichang. (2020). Use of herbal drugs to treat
COVID-19 should be with caution. The Lancet,
395(10238), 1689–1690. https://doi.org/10.1016/S01406736(20)31143-0

Hartanti, et al.

Yue, G. G.-L., Li, L., Lee, J. K.-M., Kwok, H.-F.,
Wong, E. C.-W., Li, M., Fung, K.-P., Yu, J., Chan, A.
W.-H., Chiu, P. W.-Y., & Lau, C. B.-S. (2019). Multiple
modulatory activities of Andrographis paniculata on
immune responses and xenograft growth in esophageal
cancer preclinical models. Phytomedicine, 60, article
152886. https://doi.org/10.1016/j.phymed.2019.152886.
Yue, G. G. L., Chan, B. C. L., Hon, P. M., Kennelly, E.
J., Yeung, S. K., Cassileth, B. R., Fung, K.-P., Leung, P.
C., & Lau, C. B. S. (2010). Immunostimulatory activities
of polysaccharide extract isolated from Curcuma longa.
International Journal of Biological Macromolecules,
47(3),
342–347.
https://doi.org/10.1016/j.
ijbiomac.2010.05.019.
Zandifar, A., & Badrfam, R. (2020). Iranian mental
health during the COVID-19 epidemic. Asian Journal of
Psychiatry, 51, article 101990. https://doi.org/10.1016/j.
ajp.2020.101990.
Zhang, D. H., Wu, K. L., Zhang, X., Deng, S. Q., &
Peng, B. (2020). In silico screening of Chinese herbal
medicines with the potential to directly inhibit 2019 novel
coronavirus. Journal of Integrative Medicine, 18(2),
152–158. https://doi.org/10.1016/j.joim.2020.02.005.
Zhi, H. J., Zhu, H. Y., Zhang, Y. Y., Lu, Y., Li, H.,
& Chen, D. F. (2019). In vivo effect of quantified
flavonoids-enriched extract of Scutellaria baicalensis
root on acute lung injury induced by influenza A virus.
Phytomedicine, 57, 105–116. https://doi.org/10.1016/j.
phymed.2018.12.009.
Zhou, Z., Zhu, C. S., & Zhang, B. (2020). Study on
medication regularity of traditional Chinese medicine
in treatment of COVID-19 based on data mining. China
Journal of Chinese Materia Medica, 45(6), 1248–1252.
https://doi.org/10.19540/j.cnki.cjcmm.20200220.502.

E-ISSN 2477-0612

